Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653555 · ClinicalTrials.gov registry record · NA
Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP
A NA study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 480
- Enrollment target
NCT07653555: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT07653555 is a NA study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 480 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07653555, a NA study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of two models of cascade testing in identifying at-risk family members of individuals diagnosed with familial hypercholesterolemia (FH).
Interventions
- OTHER Standard of Care
- OTHER Cascade testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2026-06-20 |
| Est. Completion | 2029-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07653555
The ClinicalTrials.gov registry entry for NCT07653555 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07653555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07653555 about?
NCT07653555 is a clinical study titled "Cascade Testing In Identifying At-risk Family Members Of Individuals With Familial Hypercholesterolemia (FH) In PCP". The purpose of this study is to evaluate the effectiveness of two models of cascade testing in identifying at-risk family members of individuals diagnosed with familial hypercholesterolemia (FH).
What is the current status of trial NCT07653555?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2026-06-20. Estimated completion is 2029-09-20.
What interventions are being tested in trial NCT07653555?
The interventions under investigation include: Standard of Care (OTHER), Cascade testing (OTHER).
Who is sponsoring clinical trial NCT07653555?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.